IMNM EPS Estimates
Immunome, Inc.
$17.20
-$0.38(-2.16%)
40
Overall
50
Value
18
Tech
52
Quality
Market Cap
$2.03B
Volume
1.16M
52W Range
$13.53 - $30.06
Target Price
$35.20
IMNM EPS estimates: the consensus estimate for Immunome, Inc.'s current fiscal year is -$2.51 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
IMNM EPS Estimates
- EPS estimate, current quarter
- $-0.68
- EPS estimate, next quarter
- $-0.70
- EPS estimate, current year
- $-2.51
- EPS estimate, next year
- $-2.70
- EPS growth, 3-year
- +7.70%
| Fiscal year | EPS |
|---|---|
| 2025 | $-2.43 |
| 2024 | $-5.00 |
| 2023 | $-5.38 |
| 2022 | $-3.09 |
| 2021 | $-2.14 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IMNM | $17.20 | -2.2% | 1.16M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |